Actionable news
0
All posts from Actionable news
Actionable news in INSY: Insys Therapeutics, Inc.,

DaVita (DVA) Beats Earnings and Revenue Estimates in Q2

DaVita Inc. DVA reported second-quarter 2017 adjusted operating earnings of 92 cents per share that surpassed the Zacks Consensus Estimate of 90 cents. However, earnings declined from $1.01 in the year-ago quarter.

Total revenue increased from $3.72 billion year over year to approximately $3.88 billion and beat the Zacks Consensus Estimate of $3.84 billion.

Segment Update

U.S. Dialysis and Related Lab Services

Total operating revenue during the second quarter was approximately $2.33 billion, up from $2.26 billion in the year-ago quarter. However, operating income was up from $449 million in the prior-year quarter to $450 million.

Davita Medical Group (DMG)

Total operating revenue during the second quarter was $1.20 billion, up from $1.06 billion in the year-ago quarter. Also, the segment’s adjusted operating loss came in at $13 million versus the loss of $102 million in the prior-year quarter.

DaVita HealthCare Partners Inc. Price, Consensus and EPS Surprise

DaVita HealthCare Partners Inc. Price, Consensus and EPS Surprise | DaVita HealthCare Partners Inc. Quote

Financial Update

Total cash and cash equivalents of DaVita declined to $712.0 million as of Jun 30, from $913.2 million as of Dec 31, 2016...


More